To the best of our knowledge, the current study is the first time that, the combination of c-Kit and Ano1 immunohistochemistry was employed to evaluate the changes to the ICC in a mouse model of diabetes and EA. This evidence concerns the gene ANO1 and intrahepatic cholangiocarcinoma.